Trials / Conditions / Active Tuberculosis

Active Tuberculosis

12 registered clinical trials studyying Active Tuberculosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundan NCT06846645	Chinese University of Hong Kong	—
Withdrawn	miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB) NCT05048381	University Hospital, Basel, Switzerland	—
Active Not Recruiting	Pulmonary Aspergillosis in Tuberculosis Patients NCT05045391	Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan	—
Completed	Performance Evaluation of the VIDAS TB-IGRA Assay. NCT04048018	BioMérieux	—
Active Not Recruiting	Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundan NCT06838780	Chinese University of Hong Kong	—
Completed	Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patien NCT03271567	Chinese University of Hong Kong	—
Completed	COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB) NCT06408129	University Hospital, Montpellier	—
Unknown	Improving the Detection of Active Tuberculosis in Accident and Emergency Departments NCT02512484	Public Health England	—
Completed	New Generation IGRA in Immunocompromised Individuals NCT02639936	Tuberculosis Network European Trialsgroup	—
Terminated	Serological Test for the Diagnosis of TB NCT02898623	University Hospital, Montpellier	—
Completed	The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study NCT02042261	Thomas Schon	—
Completed	Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis NCT01269268	Yonsei University	—